According to the HAS the vaccines approved include Moderna and Pfizer/BioNTech targeting the Omicron variant BA.1, as well as the one of Pfizer/BioNTech adapted to the BA.4 Omicron subvariants. Xinhua reported.
Three bivalent mRNA vaccines were approved by the French national health authority (HAS), against Covid-19 Omicron variants, for booster shots during the vaccination campaign that began on October 18.
The HAS stated in a statement that “the HAS confirms its recommendation for administering an additional dose of Covid-19 vaccine to persons at risk of developing severe forms of the disease as well to their families, healthcare professionals in autumn.”
According to the health authority, bivalent mRNA vaccines were not created. They are, however, updated like seasonal flu vaccines to account for the new virus that circulates during winter.
On Tuesday, September 20, the French Public Health Agency reported that 51,816 Covid-19 cases were discovered in the past 24 hours. A total of 79% of French citizens have been vaccinated.
Kundan Goyal has 6+ years of experience in news editing and market research. He has helped businesses of all sizes make strategic decisions and predict future trends. Kundan only publishes content that will help them grow their sales and revenue. He publishes business news in many different categories to help industry’s learn more about any product.In his spare time, he enjoys cooking and listening music.